AstraZeneca and Imperial spin-off VaxEquity enter into saRNA partnership

AstraZeneca has signed a collaboration deal with VaxEquity, a spin-off of Imperial College London, for discovering, developing, and commercializing the latter’s self-amplifying RNA (saRNA) therapeutics ... Read More